Shortage Of Leprosy Drugs

Shortage Of Leprosy Drugs:

Clofazimine, a key drug for treatment of leprosy, which had been in short supply in the Indian market for several months, is now “not available”, with the situation turning into a crisis over the past three months.

  • Clofazimine is one of the three essential drugs in the Multi Drug Treatment of Multibacillary Leprosy (MB-MDT) cases, along with Rifampicin and Dapsone.
  • According to the World Health Organization (WHO), leprosy is endemic in several States and Union Territories of India, with the annual case detection rate of 4.56 per 10,000 population.
  • The prevalence rate of leprosy is 0.4 per 10,000 population in the country.
  • Of the new cases detected during 2020-21, 58.1% were multibacillary, 39% were women, 5.8% were children less than 14 years of age, and 2.41% had visible deformities.
  • The rate of visible deformities was 1.1 per million population.

 

Leave a Reply

Your email address will not be published.